FDA: ‘No Convincing Evidence’ Hormones In Cosmetics Pose Health Risk
This article was originally published in The Rose Sheet
Executive Summary
FDA says it continues to monitor the issue of estrogens and progesterone in cosmetic products; however, in a recently published study an agency scientist notes that to date, FDA has found “no convincing evidence” that cosmetics containing the substances pose health risks. Products surveyed largely were found to be labeled properly, belying concerns that consumers may be exposing themselves unwittingly.